Avian Flu Matrix Protein 1 Antibody

Western Blot: Avian Flu Matrix Protein 1 Antibody [NB100-56610] - Analysis of avian flu matrix protein 1 in (A) recombinant fusion protein containing amino acids 212-225 and (B) fusion partner without these amino acids, using NB100-56610 at 0.5 ug/ml.

• Reactivity: Av, Ch
• Applications: WB
• Clonality: Polyclonal
• Host: Rabbit
• Conjugate: Unconjugated
• Concentration: 0.5 mg/ml

Avian Flu Matrix Protein 1 Antibody Summary

• Immunogen: Amino acids 212-225 of avian flu matrix protein 1 were used as the immunogen.
• Specificity: The amino acid sequence used as immunogen is 100% homologous to duck H5N1 strain and 92% homologous to chicken H5N1 strain.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Rabbit
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • Western Blot 0.5-2 ug/ml

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: PBS containing 0.2% gelatin
• Preservative: 0.05% Sodium Azide
• Concentration: 0.5 mg/ml
• Purity: Protein G purified

Alternate Names for Avian Flu Matrix Protein 1 Antibody

• Avian Influenza Matrix Protein 1

Background

An H6N1 influenza virus was isolated from a green-winged teal during the H5N1 outbreak in Hong Kong Special Administrative Region (SAR) in 1997. This virus possesses similar genes encoding internal proteins as in the human H5N1 and H9N2 influenza viruses. In 1999, influenza viruses from quail infected two humans in Hong Kong. suggesting the potential for avian influenza viruses to cross the species barrier and infect humans without prior reassortment in an intermediate host, such as the pig. The common features shared by H5N1 and H9N2 influenza viruses isolated from humans are the genes encoding the proteins of the replicating complex, the matrix protein (M) gene, the nonstructural protein (NS) gene, N1 neuraminidase (NA), This virus essentially represents the reemergence of the H5N1 influenza viruses with a different hemagglutinin (HA).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.